Please join me in this interview with Sabrina Paganoni, MD, Ph.D., who presented clinical trial results at the American Academy of Neurology 2021 Virtual Annual Meeting that promise new hope for patients with amyotrophic lateral sclerosis (ALS). A new drug, AMX0035, demonstrated functional improvement and survival benefit, according to Dr. Paganoni. Any hope for patients with this devastating disease is welcome!
Here's the 10-minute interview:
For more fascinating interviews, please check out "The Art of Medicine with Dr. Andrew Wilner" on YouTube: www.youtube.com/c/andrewwilnermdauthor
and your favorite podcast player.
Feedback is always appreciated!
Thanks for watching!